Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01787396
Recruitment Status : Completed
First Posted : February 8, 2013
Last Update Posted : April 3, 2015
Information provided by (Responsible Party):
LG Life Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2015
  Study Completion Date : March 2015